Literature DB >> 31432250

How I Approach Dysphagia.

Jooho P Kim1, Peter J Kahrilas2.   

Abstract

PURPOSE OF REVIEW: This review presents an overview of the diagnostic approach to esophageal dysphagia and summarizes recent epidemiological trends and technical advancements. RECENT
FINDINGS: The evaluation of dysphagia begins with a detailed history followed by endoscopy to evaluate for any structural abnormalities including malignancy. This is especially true given the emergence of eosinophilic esophagitis (EoE) as a dominant cause of esophageal dysphagia. In fact, it is now standard practice to obtain esophageal biopsies during endoscopy performed to evaluate dysphagia, since EoE can present without the characteristic mucosal features of rings, furrows, and exudate. Achalasia is also more frequently encountered since the introduction of high-resolution manometry (HRM) and the Chicago Classification into clinical practice. The Chicago Classification provides a stepwise diagnostic algorithm for evaluating HRM studies and systematically diagnosing esophageal motility disorders. Lastly, the functional lumen imaging probe (FLIP) is a novel technology that has added insight into both achalasia and EoE. Measuring esophageal distensibility with FLIP has useful prognostic implications for both diseases, and FLIP can identify motility abnormalities in achalasics not detected with HRM. A careful history is key to the efficient evaluation of dysphagia, and endoscopy is usually the first diagnostic study to obtain. For patients with prominent reflux symptoms, an empiric trial with proton pump inhibitors is reasonable then because reflux disease is such a common cause of dysphagia. Thereafter, patients should undergo HRM to evaluate for a motility disorder, and FLIP can provide complementary data to guide management.

Entities:  

Keywords:  Dysphagia; Esophagus; Functional luminal imaging probe; High-resolution manometer

Mesh:

Year:  2019        PMID: 31432250     DOI: 10.1007/s11894-019-0718-1

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  54 in total

Review 1.  Advances in Management of Esophageal Motility Disorders.

Authors:  Peter J Kahrilas; Albert J Bredenoord; Dustin A Carlson; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-24       Impact factor: 11.382

Review 2.  Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group.

Authors:  C P Gyawali; S Roman; A J Bredenoord; M Fox; J Keller; J E Pandolfino; D Sifrim; R Tatum; R Yadlapati; E Savarino
Journal:  Neurogastroenterol Motil       Date:  2017-05-24       Impact factor: 3.598

3.  Intraoperative measurement of esophagogastric junction cross-sectional area by impedance planimetry correlates with clinical outcomes of peroral endoscopic myotomy for achalasia: a multicenter study.

Authors:  Saowanee Ngamruengphong; Burkhard H A von Rahden; Jörg Filser; Amy Tyberg; Amit Desai; Reem Z Sharaiha; Arnon Lambroza; Vivek Kumbhari; Mohamad El Zein; Ahmed Abdelgelil; Sepideh Besharati; John O Clarke; Ellen M Stein; Anthony N Kalloo; Michel Kahaleh; Mouen A Khashab
Journal:  Surg Endosc       Date:  2015-10-20       Impact factor: 4.584

4.  Incidence and Prevalence of Achalasia in Central Chicago, 2004-2014, Since the Widespread Use of High-Resolution Manometry.

Authors:  Salih Samo; Dustin A Carlson; Dyanna L Gregory; Susan H Gawel; John E Pandolfino; Peter J Kahrilas
Journal:  Clin Gastroenterol Hepatol       Date:  2016-08-28       Impact factor: 11.382

5.  The Chicago Classification of esophageal motility disorders, v3.0.

Authors:  P J Kahrilas; A J Bredenoord; M Fox; C P Gyawali; S Roman; A J P M Smout; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2014-12-03       Impact factor: 3.598

6.  Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.

Authors:  Trilokesh Kidambi; Erin Toto; Nancy Ho; Tiffany Taft; Ikuo Hirano
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

Review 7.  Functional lumen imaging probe: The FLIP side of esophageal disease.

Authors:  Dustin A Carlson
Journal:  Curr Opin Gastroenterol       Date:  2016-07       Impact factor: 3.287

8.  The contractile deceleration point: an important physiologic landmark on oesophageal pressure topography.

Authors:  J E Pandolfino; E Leslie; D Luger; B Mitchell; M A Kwiatek; P J Kahrilas
Journal:  Neurogastroenterol Motil       Date:  2009-12-27       Impact factor: 3.598

9.  High-Resolution Manometry Improves the Diagnosis of Esophageal Motility Disorders in Patients With Dysphagia: A Randomized Multicenter Study.

Authors:  Sabine Roman; Laure Huot; Frank Zerbib; Stanislas Bruley des Varannes; Guillaume Gourcerol; Benoit Coffin; Alain Ropert; Adeline Roux; François Mion
Journal:  Am J Gastroenterol       Date:  2016-02-02       Impact factor: 10.864

10.  Assessment of Clinical Outcomes after Peroral Endoscopic Myotomy via Esophageal Distensibility Measurements with the Endoluminal Functional Lumen Imaging Probe.

Authors:  In Kyung Yoo; Sang Ah Choi; Won Hee Kim; Sung Pyo Hong; Ozlem Ozer Cakir; Joo Young Cho
Journal:  Gut Liver       Date:  2019-01-15       Impact factor: 4.519

View more
  3 in total

Review 1.  A Comparative Assessment of the Diagnosis of Swallowing Impairment and Gastroesophageal Reflux in Canines and Humans.

Authors:  Tarini V Ullal; Stanley L Marks; Peter C Belafsky; Jeffrey L Conklin; John E Pandolfino
Journal:  Front Vet Sci       Date:  2022-06-09

2.  Endoscopic Findings and Their Association With Gender, Age and Duration of Symptoms in Patients With Dysphagia.

Authors:  Hafsa Rashid; Khush Bakht; Amna Arslan; Amna Ahmad
Journal:  Cureus       Date:  2020-10-30

3.  Esophageal Motility Disorders in the Natural History of Acid-Dependent Causes of Dysphagia and Their Influence on Patients' Quality of Life-A Prospective Cohort Study.

Authors:  Joanna Sarbinowska; Benita Wiatrak; Dorota Waśko-Czopnik
Journal:  Int J Environ Res Public Health       Date:  2021-10-23       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.